STANDARD CHARTERED BANK ZAMBIA PLC (SCBL)
Lusaka Stock Exchange · Zambia · prices in ZMW · close of 21 Oct 2026
Key indicators
| Last close | ZMW 1.130 |
|---|---|
| 52-week range | 1.100 – 2.600 |
| Return, 1 month / 3 months | −7.4% / −11.7% |
| Return, 1 year / 3 years | −56.4% / −19.3% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 43.5% |
| Worst drawdown (1 year) | -57.7% |
| Average daily value traded | 0.01M ZMW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Standard Chartered Bank Zambia is a commercial bank based in Lusaka that serves individuals, small businesses, corporations and institutions across Zambia. It offers everyday banking accounts, savings and deposit products, personal and business loans, credit and debit cards, and mortgage finance. For companies and larger clients it provides trade finance, cash management, treasury services and lending. Customers use its branch network and digital channels for payments, transfers and account management.
On this site STANDARD CHARTERED BANK ZAMBIA PLC appears as a stock on the Lusaka Stock Exchange (Zambia), code SCBL, with prices in Zambian kwacha (ZMW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
STANDARD CHARTERED BANK ZAMBIA PLC (SCBL) trades on the Lusaka Stock Exchange in Zambia. It last closed at ZMW 1.130 on 21 October 2026.
Its price-based Market X-Ray is 18 out of 100 (a weak price profile), ranking 24 of 26 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 56.4% and over the last three months it fell 11.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Lusaka Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.8% | ||
| From 52-week high | -56.5% | ||
| Momentum | 18 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.7% | ||
| 6-month return | -12.4% | ||
| 12-month return, skipping the last month | -52.9% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.7% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M ZMW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.4% |
|---|---|
| 1 month | −7.4% |
| 3 months | −11.7% |
| 6 months | −12.4% |
| 1 year | −56.4% |
| 3 years | −19.3% |
| 5 years | +28.4% |
Signals
| 50-day / 200-day average | 1.221 / 1.502 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.014 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Lusaka Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.